Elevance Health Hits New 52-Week High at $416.50

Elevance Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 416.50 on June 5, 2026. This achievement marks a notable point in the stock's performance, especially considering its one-year performance of -22.51%, contrasting sharply with the S&P 500's gain of 24.32% during the same period. As a large-cap company in the healthcare services industry, Elevance Health boasts a market capitalization of USD 63,208 million. The stock's price-to-earnings (P/E) ratio stands at 11.00, indicating its valuation relative to earnings. Additionally, the company offers a dividend yield of 2.46%, providing a return to its shareholders. With a debt-to-equity ratio of -0.09 and a return on equity of 12.90%, Elevance Health demonstrates a solid financial position. The price-to-book ratio is recorded at 1.44, reflecting the company's valuation in relation to its assets. The stock's previous 52-week low was USD 273.71, highlighting the significant upward movement it has experienced recently.